Total Payments
$594.67
2024 Payments
$46.60
Companies
11
Transactions
43
Medicare Patients
1,535
Medicare Billing
$159,381
Payment Breakdown by Category
Food & Beverage$594.67 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $594.67 | 39 | 100.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$594.67
39 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $172.66 | 10 | $0 (2024) |
| ABBVIE INC. | $121.36 | 8 | $0 (2023) |
| Organon LLC | $88.44 | 7 | $0 (2022) |
| Allergan Inc. | $70.63 | 4 | $0 (2019) |
| PFIZER INC. | $42.11 | 3 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $24.71 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $23.84 | 2 | $0 (2019) |
| Gilead Sciences, Inc. | $23.14 | 1 | $0 (2023) |
| UCB, Inc. | $16.26 | 1 | $0 (2018) |
| Daiichi Sankyo Inc. | $11.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.60 | 4 | Janssen Biotech, Inc. ($46.60) |
| 2023 | $103.10 | 7 | ABBVIE INC. ($34.87) |
| 2022 | $143.80 | 12 | Organon LLC ($59.83) |
| 2021 | $89.15 | 6 | Janssen Biotech, Inc. ($33.07) |
| 2020 | $11.95 | 1 | Intercept Pharmaceuticals, Inc. ($11.95) |
| 2019 | $87.48 | 6 | Allergan Inc. ($32.68) |
| 2018 | $48.91 | 3 | Janssen Biotech, Inc. ($18.82) |
| 2017 | $63.68 | 4 | Allergan Inc. ($37.95) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Immunology | ||||||
| 05/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Immunology | ||||||
| 02/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Immunology | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 11/22/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/26/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Immunology | ||||||
| 08/10/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.14 | General |
| 01/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: IMMUNOLOGY | ||||||
| 2023 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 12/13/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/16/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: INFLIXIMAB | ||||||
| 08/16/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: INFLIXIMAB | ||||||
| 07/12/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: INFLIXIMAB | ||||||
| 07/12/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $1.11 | General |
| Category: INFLIXIMAB | ||||||
| 06/13/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Immunology | ||||||
| 04/18/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Immunology | ||||||
| 03/29/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: INFLIXIMAB | ||||||
| 03/04/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: IMMUNOLOGY | ||||||
| 01/27/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Immunology | ||||||
| 2022 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 11/22/2021 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: Immunology | ||||||
| 08/24/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 377 | 628 | $541,826 | $50,438 |
| 2022 | 8 | 350 | 385 | $437,220 | $39,387 |
| 2021 | 10 | 416 | 524 | $284,874 | $38,106 |
| 2020 | 11 | 392 | 473 | $238,470 | $31,450 |
Total Patients
1,535
Total Services
2,010
Medicare Billing
$159,381
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 120 | 120 | $207,000 | $14,988 | 7.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 51 | 51 | $91,851 | $10,358 | 11.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 169 | $25,688 | $5,613 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 74 | $18,266 | $5,547 | 30.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 93 | $9,300 | $4,121 | 44.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $24,156 | $3,042 | 12.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 38 | $57,038 | $2,025 | 3.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 18 | 20 | $87,260 | $1,713 | 2.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 22 | $4,454 | $1,378 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,888 | $969.63 | 24.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,925 | $682.30 | 5.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 111 | 112 | $173,250 | $13,700 | 7.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 26 | 28 | $47,621 | $5,317 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 69 | $15,159 | $5,136 | 33.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 20 | 20 | $25,472 | $3,527 | 13.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 58 | 59 | $77,537 | $3,429 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 43 | $7,545 | $3,106 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,786 | $2,302 | 39.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 18 | 21 | $71,445 | $1,708 | 2.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $13,405 | $1,162 | 8.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 96 | 96 | $115,200 | $12,832 | 11.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 68 | $12,566 | $5,538 | 44.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 19 | 19 | $26,600 | $3,766 | 14.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 44 | $7,524 | $3,242 | 43.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 51 | 133 | $21,280 | $3,057 | 14.4% |
About Dr. Edward Frech, MD
Dr. Edward Frech, MD is a Gastroenterology healthcare provider based in St George, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942496757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Frech, MD has received a total of $594.67 in payments from pharmaceutical and medical device companies, with $46.60 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($594.67).
As a Medicare-enrolled provider, Frech has provided services to 1,535 Medicare beneficiaries, totaling 2,010 services with total Medicare billing of $159,381. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location St George, UT
- Active Since 09/15/2007
- Last Updated 10/16/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1942496757
Products in Payments
- STELARA (Biological) $157.09
- RENFLEXIS (Drug) $88.44
- LINZESS (Drug) $51.93
- SKYRIZI (Biological) $49.87
- HUMIRA (Biological) $42.94
- XELJANZ (Drug) $42.11
- OCALIVA (Drug) $24.71
- RENFLEXIS (Biological) $23.84
- VIBERZI (Drug) $18.70
- Cimzia (Drug) $16.26
- TREMFYA (Drug) $15.57
- CREON (Drug) $14.34
- Humira (Biological) $14.21
- INJECTAFER (Drug) $11.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in St George
Mr. Brien Miller, D.o, D.O
Gastroenterology — Payments: $4,405
Gastroenterology $4,405
James Bown, M.d, M.D
Gastroenterology — Payments: $4,284
Gastroenterology $4,284
Dr. Roger Siddoway, M.d, M.D
Gastroenterology — Payments: $2,960
Gastroenterology $2,960
Christoph Woerlein, Md, MD
Gastroenterology — Payments: $2,621
Gastroenterology $2,621
Dr. Christopher Flannery, Md, MD
Gastroenterology — Payments: $553.25
Gastroenterology $553.25
Dr. Allan Gunnerson, D.o, D.O
Gastroenterology — Payments: $179.26
Gastroenterology $179.26